The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,846.00
Bid: 1,826.00
Ask: 1,840.00
Change: 0.00 (0.00%)
Spread: 14.00 (0.767%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,846.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ruthin Site Visit

3 Nov 2022 07:00

RNS Number : 1089F
Genus PLC
03 November 2022
 

3 November 2022

Genus plc

 

Ruthin Site Visit

 

Genus plc (LSE: GNS), a leading global animal genetics company, is today hosting a site visit for sell side analysts and institutional investors to its production site in Ruthin, North Wales. The visit will showcase Genus's world class beef and dairy bulls, as well as its industry leading Intelligen technology.

No new information regarding current trading will be disclosed during the site visit.

Enquiries:

Genus plc

Stephen Wilson, Chief Executive Officer

Alison Henriksen, Chief Financial Officer

Tel: 01256 345970

Buchanan

Charles Ryland / Chris Lane / Verity Parker

Tel: 0207 466 5000

 

About Genus

Genus advances animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

Genus's worldwide sales are made in over 75 countries under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. Genus's customers' animals produce offspring with greater production efficiency and quality, and our customers use them to supply the global dairy and meat supply chains.

Genus's competitive edge comes from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

Headquartered in Basingstoke, United Kingdom, Genus companies operate in over 24 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKBBDNBDDADK
Date   Source Headline
31st Jan 20065:06 pmRNSAdditional Listing
10th Jan 20063:12 pmRNSAdditional Listing
15th Dec 20056:34 pmRNSHolding(s) in Company
15th Dec 20056:20 pmRNSHolding(s) in Company
7th Dec 20057:01 amRNSDirectors' Share Awards
2nd Dec 20058:38 amRNSOffer Update
29th Nov 20057:02 amRNSInterim Results
25th Nov 200512:54 pmRNSOffer Update
22nd Nov 20057:02 amRNSOffer Update
18th Nov 20059:16 amRNSSchedule 1 - Genus PLC
14th Nov 200512:51 pmRNSOffer Update
11th Nov 20054:15 pmRNSRule 8.1- (Sygen)
8th Nov 20052:05 pmRNSOffer Update
4th Nov 20052:40 pmRNSRule 8.1- (Sygen)
3rd Nov 200512:48 pmRNSOffer Update
3rd Nov 20057:00 amRNSNotice of Interim Results
2nd Nov 20055:20 pmRNSRule 8.1- (Sygen)
2nd Nov 200510:19 amRNSOffer Update
1st Nov 20056:05 pmRNSRule 8.1- (Sygen)
1st Nov 200512:59 pmRNSOffer Document Posted
28th Oct 20055:48 pmRNSDisposal
28th Oct 20057:01 amRNSOffer for Sygen Int. plc
10th Oct 20057:00 amRNSPre-Close Trading Update
18th Aug 20054:13 pmRNSResult of AGM
18th Aug 20057:00 amRNSAGM Statement
19th Jul 200511:36 amRNSIssue of Equity
12th Jul 200512:31 pmRNSIssue of Equity
20th Jun 200511:37 amRNSIssue of Equity
8th Jun 20052:33 pmRNSIssue of Equity
24th May 20057:01 amRNSFinal Results
4th May 20054:59 pmRNSNotice of Results
2nd Mar 20055:33 pmRNSDirector Shareholding
19th Jan 20058:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.